USANA健康科学公司(USANA)今日股价盘中大涨5.13%,引发市场关注。公司发布的2024年第三季度业绩显示,调整后每股收益为0.56美元,高于华尔街分析师平均预期的0.49美元。
数据显示,USANA本季度净收入为1061万美元,营收为2.0022亿美元,同比下降6.2%。尽管营收低于分析师预期的2.0577亿美元,但利润超预期成为推升股价的主要因素。
华尔街分析师目前对USANA的股票给予"持有"的平均评级,暂无"买入"或"卖出"的建议。分析师对该公司未来12个月的目标股价中位数为46.5美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.